Summary
Rheumatoid arthritis (RA) is estimated to occur in 0.3 to 3% of the general population. Up to one-third of RA patients first present for treatment after the age of 60 years (elderly-onset RA). The overall frequency in individuals older than 65 is increased, so that 30 to 40% of RA patients treated in rheumatology centres are > 60 years of age.
Optimal management of all RA patients includes physical therapy, medications, both nonsteroidal anti-inflammatory drugs (NSAIDs) and remittive agents, and, in some cases, surgery. In the elderly, these treatment modalities at times need to be altered to accommodate age-related changes in body mechanics and organ function. Thus, the approach to physical therapy in older patients is different than in the young. There are fewer rest periods and more passive exercises. Drug treatment must also be modified, since NSAIDs and several remittive agents are more hazardous in elderly patients. Indications for orthopaedic procedures may also be different. The long term management of RA requires a delicate balance of benefit and risk. It is wise to begin with the least toxic medications. However, if necessary, potentially toxic medications can be given cautiously, with close monitoring for adverse effects.
Similar content being viewed by others
References
Abramson SB, Weissman G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis and Rheumatism 32: 1–9, 1989
Adler E. Rheumatoid arthritis in old age. Israel Journal of Medical Sciences 2: 607–613, 1966
Advenier C, Roux A, Gobert C, Massias P, Varoquaux O, et al. Pharmacokinetics of ketoprofen in the elderly. British Journal of Clinical Pharmacology 16: 65–70, 1983
Agrawal NM, Roth S, Graham DY, White RH, Germain B, et al. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized controlled study. Annals of Internal Medicine 115: 195–200, 1991
Als OS, Gotfredsen A, Christiansen C. The effect of glucocorticoids on bone mass in rheumatoid arthritis patients: influence of menopausal state. Arthritis and Rheumatism 28: 369–375, 1985
Antillon M, Cominelli F, Lo S, Moran M, Somberg K, et al. Effects of oral prostaglandins on indomethacin-induced renal failure in patients with cirrhosis and ascites. Journal of Rheumatology 17 (Suppl. 20): 46–49, 1990
Armstrong CP, Blower AL. Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 28: 527–532, 1987
Arnold M, Schrieber L, Brooks P. Immunosuppressive drugs and corticosteroids in the treatment of RA. Drugs 36: 340–363, 1988
Bently G, Dowd GSE. Surgical treatment of arthritis in the elderly. Clinics in Rheumatic Diseases 12: 291–327, 1986
Berg KJ, Talseth T. Acute renal effects of sulindac and indomethacin in chronic renal failure. Clinical Pharmacology and Therapeutics 37: 447–452, 1985
Bergstrom G, Anders B, Sorensen LB, Sundh V, Svanborg A. Prevalence of Rheumatoid arthritis, osteoarthritis, chondrocalcinosis and gouty arthritis at age 79. Journal of Rheumatology 13: 527–534, 1986
Berkowitz JM, Adler SN, Sharp JT, Warner CW. Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine. Journal of Clinical Gastroenterology 8: 377–380, 1986
Bianchi-Porro G, Pertillo M, Ardizzone S. Salsalate in the treatment of RA: a double blind clinical and gastroscopic trial versus piroxicam. Journal of International Medical Research 17: 320–323, 1989
Blackshear JL, Napier JS, Davidman M, Stillman MT. Renal complications of nonsteroidal antiinflammatory drugs; identification and monitoring of those at risk. Seminars in Arthritis and Rheumatism 14: 163–174, 1985
Boers M, Dijkmans BAC, Breedveld FC, Camps JAJ, Chang PC, et al. No effect of misoprostol on renal function of rheumatoid patients treated with diclofenac. British Journal of Rheumatology 30: 56–59, 1991
Brater DC, Anderson S, Baird B, Campbell WB. Sulindac does not spare the kidney. Clinical Pharmacology and Therapeutics 35: 229–233, 1984
Brawer AE. Anarthritic rheumatoid arthritis: The polymyalgia dilemma. Abstract no. D93. Arthritis and Rheumatism 34: S179, 1991
Brick JE, Moreland LW, Al-Kawas F, Chang WW, Layne RD, et al. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients. Seminars in Arthritis and Rheumatism 19: 31–44, 1989
Bridges SC, Alarcon GS, Koopman WJ. Methotrexate-induced liver abnormalities in rheumatoid arthritis. Journal of Rheumatology 16: 1180–1183, 1989
Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs — differences and similarities. New England Journal of Medicine 324: 1716–1725, 1991
Brown JW, Sones DA. The onset of rheumatoid arthritis in the aged. Journal of the American Geriatrics Society 15: 873–881, 1967
Buckley LM, Vacek PM, Cooper SM. Administration of folinic acid after methotrexate in patients with rheumatoid arthritis. Journal of Rheumatology 17: 1158–1161, 1990
Bunning RD, Barth WF. Sulindac: a potentially renal sparing nonsteroidal anti-inflammatory drug. Journal of the American Medical Association 248: 2864–2867, 1982
Caldwell JR, Furst DE. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Seminars in Arthritis and Rheumatism 21: 1–11, 1991
Calkins E. Arthritis in the elderly. Bulletin on the Rheumatic Diseases 40: 11–13, 1991
Campion G, Maddison PJ, Goulding N, James I, Ahern MJ, et al. The Felty Syndrome: A case-matched study of clinical manifestations and outcome, serologic features and immunogenetic associations. Medicine 69: 69–79, 1990
Cannon GW, Jackson CG, Samuelson CO, Ward JR, Williams HJ, et al. Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review. Seminars in Arthritis and Rheumatism 15: 106–118, 1985
Caruso I, Bianchi-Porro G. Gastroscopic evaluation of anti-inflammatory agents. British Medical Journal 280: 75–78, 1980
Cecil RL, Kammerer WH. Rheumatoid arthritis in the elderly. American Journal of Medicine 10: 439–445, 1951
Ceuppens JL, Rodriguez MA, Goodwin JS. Nonsteroidal anti-inflammatory agents inhibit the synthesis of IgM rheumatoid factor in vitro. Lancet 1: 528–530, 1982
Chaffman M, Brogden RN, Heel RC, Speight TM, Avery GS, et al. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis. Drugs 27: 378–424, 1984
Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. New England Journal of Medicine 310: 279–283, 1984
Clements PJ, Davis J. Cytotoxic drugs: Their clinical application to the rheumatic diseases. Seminars in Arthritis and Rheumatism 15: 231–254, 1986
Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. New England Journal of Medicine 310: 563–572, 1984
Collier DSJ, Pain JA. Nonsteroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 26: 359–363, 1985
Corrigan AB, Robinson RG, Terenty TR, Dick-Smith JB, Walters D. Benign rheumatoid arthritis of the aged. British Medical Journal 1: 444–446, 1979
Croker Jr, Cotton PB, Boyle AC, Kinsella P. Cimetidine for peptic ulcer in patients with arthritis. Annals of the Rheumatic Diseases 39: 275–278, 1980
Cush JJ, Lipsky PE, Postlethwaite AE, Schrohenloher RE, Saway A, et al. Correlation of serological indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis and Rheumatism 33: 19–28, 1990
Cush JJ, Nichols AA, Strand V, Lipsky PE. Treatment of rheumatoid arthritis patients with an anti-CD5 immuno-conjugate. Abstract no. C158. Arthritis and Rheumatism 34: S159, 1991
Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ. Abolition by omeprazole of aspirin-induced gastric mucosal injury in man. Gut 31: 514–517, 1990
Davis A, Day RO, Begg EJ. Interactions between nonsteroidal anti-inflammatory drugs and antihypertensives and diuretics. Australian and New Zealand Journal of Medicine 16: 537–546, 1986
Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, et al. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis and Rheumatism 28: 987–994, 1985
Delafuente JC, Osborn TG. Review of auranofin, an oral chrysotherapeutic agent. Clinical Pharmacy 3: 121–127, 1984
Ditunno J, Ehrlich GE. Care and training of elderly patients with rheumatoid arthritis. Geriatrics 25: 164–172, 1970
Dordick JR. Rheumatoid arthritis in the elderly. Journal of the American Geriatrics Society 4: 588–591, 1956
Dykman TR, Gluck OS Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis and Rheumatism 28: 361–368, 1985
Easterbrook M. Ocular effects and safety of antimalarial agents. American Journal of Medicine 85: 23–29, 1988
Ehrlich GE, Katz WA, Cohen SA. Rheumatoid Arthritis in the aged. Geriatrics 25: 103–113, 1970
Ehsanullah RS, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine. British Medical Journal 297: 1017–1021, 1988
Faulkner G, Prichard P, Somerville K, Langman MJ. Aspirin and bleeding peptic ulcers in the elderly. British Medical Journal 297: 1311–1313, 1988
Favre L, Glasson PH, Riondel A, Vallotton MB. Interactions of diuretics and nonsteroidal anti-inflammatory drugs in man. Clinical Science 64: 407–415, 1983
Felson DT, Anderson JJ, Meenan RF. Comparing second line drugs for RA: Efficacy/toxicity tradeoffs. Abstract no. 122. Arthritis and Rheumatism 34: S53, 1991
Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factors. American Journal of Medicine 91: 213–222, 1991
Furst DE. Clinically important interactions of nonsteroidal anti-inflammatory drugs with other medications. Journal of Rheumatology 15 (Suppl. 17): 58–62, 1988
Furst DE, Kremer JM. Methotrexate in rheumatoid arthritis. Arthritis and Rheumatism 31: 305–314, 1988
Gabriel S, Creagan E, O’Fallon WM, Jaquith J, Bunch T. Treatment of rheumatoid arthritis with higher dose intravenous methotrexate. Journal of Rheumatology 17: 460–465, 1990
Gall EP, Caperton JF, McComb JE, Messner R, Multz CV, et al. Clinical comparison of ibuprofen, fenoprofen calcium naproxen and tolmentin sodium in rheumatoid arthritis. Journal of Rheumatology 9: 402–407, 1982
Garber EK, Fan PT, Bluestone R. Realistic guidelines of corticosteroid therapy in rheumatic disease. Seminars in Arthritis and Rheumatism 11: 231–256, 1981
Gerber LH, Rooney PJ, McCarthy DM. Healing of peptic ulcers during continuing anti-inflammatory drug therapy in rheumatoid arthritis. Journal of Clinical Gastroenterology 3: 7–11, 1981
Goodwin JS, Regan M. Brief report: Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis and Rheumatism 25: 1013–1015, 1982
Gordon DA. Gold compounds. In Kelley et al. (Eds.) Textbook of rheumatology, 3rd ed., pp. 804–823, WB Saunders Co., Philadelphia, 1989
Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicenter, double-blind, placebo-controlled trial. Lancet 2: 1277–1280, 1988
Gray RES, Doherty SM, Galloway J, Coulton L, Broe M, et al. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis and Rheumatism 34: 287–295, 1991
Greenblatt DJ, Abernathy DR, Matlis R, Harmatz JS, Shader RI. Absorption and disposition of ibuprofen in the elderly. Arthritis and Rheumatism 27: 1066–1069, 1984
Griffin MR, Piper JM, Daugherty JR, Snowdem M, Ray WA. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Annals of Internal Medicine 114: 257–263, 1991
Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Annals of Internal Medicine 109: 359–363, 1988
Hahn BH. Osteoporosis: Diagnosis and management. Bulletin on the Rheumatic Diseases 38: 5–8, 1988
Hara KS, Ballard DJ, Ilstrup DM, Connolly DC, Vollertsen RS. Rheumatoid pericarditis: Clinical features and survival. Medicine 69: 81–91, 1990
Harris ED. Management of rheumatoid arthritis. In Kelley et al. (Eds.) Textbook of rheumatology, 3rd ed., pp. 982–992, WB Saunders Co., Philadelphia, 1989
Harris Jr ED, Emkey RD, Nichols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: A double blind study. Journal of Rheumatology 10: 713–721, 1983
Hart D, Lifschitz MD. Renal physiology of the prostaglandins and the effects of nonsteroidal anti-inflammatory agents on the kidney. American Journal of Nephrology 7: 408–418, 1987
Healey LA, Sheets PK. The relation of polymyalgia rheumatica to rheumatoid arthritis. Journal of Rheumatology 15: 750–752, 1988
Hicks JE. Exercise in patients with inflammatory arthritis and connective tissue disease. Rheumatic Disease Clinics of North America 16: 845–870, 1990
Higgs GA, Moncada S, Vane JR. The mode of action of anti-inflammatory drugs which prevent peroxidation of arachidonic acid. Rheumatic Disease Clinics of North America 6: 675–693, 1980
Hoppmann RA, Peden JG, Ober SK. Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Archives of Internal Medicine 151: 1309–1313, 1991
Horneff G, Burmester GR, Emmrich F, Kolden JR. Treatment of rheumatoid arthritis with an anti-CD 4 monoclonal antibody. Arthritis and Rheumatism 34: 129–140, 1991
Jaffe IA. Penicillamine. In Kelley et al. (Eds.) Textbook of rheumatology, 3rd ed., pp. 824–832, WB Saunders Co., Philadelphia, 1989
Jaszweski R. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal antiinflammatory drug therapy. Journal of Clinical Gastroenterology 12: 10–13, 1990
Jaszweski RJ, Cal-Zada R, Dhar R. Persistence of gastric ulcers caused by plain aspirin or nonsteroidal anti-inflammatory agents in patients treated with a combination of cimetidine, antacids, and enteric-coated aspirin. Digestive Diseases and Sciences 34: 1361–1364, 1989
Jick SS, Perera DR, Walker AM, Jick H. Nonsteroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Clinical Gastroenterology 2: 380–382, 1987
Jiranek GC, Kimmey MB, Saunders DR, Willson RA, Shanahan W, et al. Misoprostol reduces gastroduodenal injury from one week of aspirin. Gastroenterology 96: 656–661, 1989
Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Seminars in Arthritis and Rheumatism 20: 256–272, 1991
Jokl P. Prevention of disuse muscle atrophy in chronic arthritides. Rheumatic Disease Clinics of North America 16: 837–844, 1990
Joyce DA, Will RK, Hoffman DM, Laing B, Blackbourn SJ. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Annals of the Rheumatic Diseases 50: 913–914, 1991
Kean WF, Anastassiades TP, Dwosh IL, Ford PM, Kelly WG, et al. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly. Journal of the American Geriatrics Society 30: 94–100, 1982
Kean WF, Bellamy N, Brooks PM. Gold therapy in the elderly rheumatoid arthritis patient. Arthritis and Rheumatism 26: 705–711, 1983
Klippel JH, Strober S, Wofsy D. New therapies for the rheumatic diseases. Bulletin on the Rheumatic Diseases 38: 16–19, 1989
Koopmans PP, Thien TH, Gribnau FWJ. Influence of nonsteroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. British Medical Journal 289: 1492–1494, 1984
Kremer JM, Kaye NW, Kaye GI. Follow-up electron microscopic analysis of sequential liver biopsies from patients with rheumatoid arthritis treated with methotrexate. Abstract no. 17. Arthritis and Rheumatism 34: S35, 1991
Kushner I. Does aggressive therapy of rheumatoid arthritis affect outcome? Journal of Rheumatology 16: 1–3, 1989
Laan R, van Riel P, van Erning L, Lemmens A, Ruijs S, et al. Short term effects of low dose prednisone therapy on bone mineral density in patients with rheumatoid arthritis. Abstract no. 147. Arthritis and Rheumatism 34: S90, 1991
LaCava JE, Hughes JM, Raddatz DA. Low dose prednisone, 5 mg, suppresses the hypothalamic-pituitary-adrenal axis. Abstract no. 168. Arthritis and Rheumatism 34: S125, 1991
Lamy PP. Renal effects of nonsteroidal anti-inflammatory drugs: heightened risk to the elderly? Journal of the American Geriatrics Society 34: 361–365, 1986
Lance N, Curran JJ. Long term evaluation of late onset rheumatoid arthritis: Natural history and therapeutic requirements. Abstract no. 154. Arthritis and Rheumatism 33: S97, 1990
Langman MJS. Ulcer complications and nonsteroidal anti-inflammatory drugs. American Journal of Medicine 84 (Suppl. 2A): 15–19, 1988
Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other antiinflammatory agents. American Journal of Medicine 76: 19–24, 1984
Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, et al. Double-blind placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 95: 289–294, 1988
Lanza FL, Fakouhi D, Rubin A, Davis RE, Rack MF, et al. A double blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. American Journal of Gastroenterology 84: 633–636, 1989a
Lanza FL, Rack MF, Doucette M, Ekholm B, Goldlust B, et al. An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen. Journal of Rheumatology 16: 1570–1574, 1989b
Lanza FL, Royer GL, Nelson RS, Chen TT, Seckman CE, et al. A comparative endoscopic evaluation of the damaging effects of nonsteroidal antiinflammatory agents on the gastric and duodenal mucosa. American Journal of Gastroenterology 75: 17–21, 1981
Laporte JR, Carne X, Vidal X, Moreno V, Juan J, et al. Upper gastrointestinal bleeding in relation to previous use of analgesics and nonsteroidal anti-inflammatory drugs. Lancet 337: 85–89, 1991
Lauven PM, Nadstawek J, Albrecht S. The safe use of anaesthetics and muscle relaxants in older surgical patients. Drugs & Aging 3: 502–509, 1993
Lemmel EM. Multicenter double-blind trial of interferon-gamma versus placebo in rheumatoid arthritis. Abstract no. 120. Arthritis and Rheumatism 34: S52, 1991
Lequesne M. Alternative therapies for high-risk elderly rheumatic patients. Gerontology 34 (Suppl. 1): 33–41, 1988
Lockie LM, Gomez E, Smith DM. Low dose adrenocorticosteroids in the management of elderly patients with rheumatoid arthritis: selected examples and summary of efficacy in the long term management of 97 patients. Seminars in Arthritis and Rheumatism 12: 373–381, 1983
Mackenzie AH, Scherbel AL. Chloroquine and hydroxychloroquine in rheumatological therapy. Rheumatic Disease Clinics of North America 6: 545–566, 1980
Madhok R, Torley HI, Capell HA. A study of the long term efficacy and toxicity of cyclosporin A in rheumatoid arthritis. Journal of Rheumatology 18: 1485–1489, 1991
Mannich C, Malchow-Moller A, Andersen JR, Pedrsen C, Hansen TM, et al. Randomised study of the influence of nonsteroidal antiinflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut 28: 226–229, 1987
Marks JS, Power BJ. Is chloroquine obsolete in treatment of rheumatic disease? Lancet 1: 371–373, 1979
Matsouka C, Babiolakis D, Athanasiou P, Iliopoulos A, Sfyroera C, et al. Clinical and laboratory associations between late-onset RA and early-onset RA. 12th European Congress of Rheumatology, Budapest, June 30–July 6, 1991. Abstracts, p.324, 1991
McCarty DJ. Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide. Arthritis and Rheumatism 15: 157–163, 1972
McCarthy DM. Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology 96: 662–674, 1989
McKendry RJR, Dale P. Methotrexate treatment termination in patients with rheumatoid arthritis. Abstract no. 145. Arthritis and Rheumatism 34: S90, 1991
Minta JO, Williams MD. Some nonsteroidal antiinflammatory drugs inhibit the generation of Superoxide anions by activated polymorphs by blocking ligand-receptor interactions. Journal of Rheumatology 12: 751–757, 1985
Mitchell D. Epidemiology. In Utsinger et al. (Eds) Rheumatoid arthritis, pp. 133–1373, JB Lippincott, Philadelphia, 1985
Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis and Rheumatism 33: 9–18, 1990
Nesher G, Moore TL, Zuckner J. Rheumatoid arthritis in the elderly. Journal of the American Geriatrics Society 39: 284–294, 1991
Nesher G, Zimran A, Hershko C. Reduced incidence of hyperkalemia and azotemia in patients receiving sulindac compared with indomethacin. Nephron 48: 291–295, 1988
Neumann V, Hopkins R, Dixon J, Watkins A, Bird H, et al. Combination therapy with pulse methylprednisolone in rheumatoid arthritis. Annals of the Rheumatic Diseases 44: 747–751, 1985
Nickander R, McMahon FG, Ridolfo AS. Nonsteroidal anti-inflammatory agents. Annual Review of Pharmacology and Toxicology 19: 469–490, 1979
Nusslein HG, Herbst M, Manger BG, Gramatzki M, Burmester GR, et al. Total lymphoid irradiation in patients with refractory rheumatoid arthritis. Arthritis and Rheumatism 28: 1205–1210, 1985
Nuver-Zwart IH, van Riel PLCM, van de Putte LBA, Gribnau FWJ. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Annals of the Rheumatic Diseases 48: 389–395, 1989
O’Callaghan JW, Brooks PM. Disease-modifying agents and immunosuppressive drugs in the elderly. Rheumatic Disease Clinics of North America 12: 275–289, 1986
Ouslander JG. Drug therapy in the elderly. Annals of Internal Medicine 95: 711–722, 1981
Owen DS. Aspiration and injection of joints and soft tissues. In Kelley et al. (Eds.) Textbook of rheumatology, 3rd ed., pp. 621–636, WB Saunders Co., Philadelphia, 1989
Paulus HE. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. Arthritis and Rheumatism 33: 113–120, 1990
Pertuiset E, Liote F, Chevret S, Bardin T, Dryll A, et al. Treatment of rheumatoid arthritis with sulfasalazine: Treatment continuation and adverse effects. Abstract no. 157. Arthritis and Rheumatism 34: S159, 1991
Pinals RS, Kaplan SB, Lawson JG, Hepburn B. Sulfasalazine in rheumatoid arthritis. Arthritis and Rheumatism 29: 1427–1434, 1986
Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid user and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs. Annals of Internal Medicine 114: 735–740, 1991
Richardson CJ, Blocka KLN, Ross SG, Verbeeck RK. Effects of age and sex on piroxicam disposition. Clinical Pharmacology and Therapeutics 37: 13–18, 1985
Ritch AES, Perera WNR, Jones CJ. Pharmacokinetics of azapropazone in the elderly. British Journal of Clinical Pharmacology 14: 116–119, 1982
Robinson HG. Multidisciplinary ambulatory care for the elderly arthritis patient. In Moskowitz and Haug (Eds.) Arthritis and the elderly, p. 146–149, Springer, New York, 1986
Robinson MG, Griffin Jr JW, Bowers J. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs. Digestive Diseases and Sciences 34: 424–428, 1989
Roth SH. NSAID and gastropathy: A rheumatologist’s review. Journal of Rheumatology 15: 912–919, 1988
Roth SH, Bennett RE, Mitchell CS, Hartman RJ. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long term evaluation. Archives of Internal Medicine 147: 1798–1801, 1987
Rynes RI. Antimalarial drugs. In Kelley et al. (Eds.) Textbook of Rheumatology, 3rd ed., pp. 729–803, WB Saunders Co., Philadelphia, 1989
Salvetti A, Pedrinelli R, Alberici P, Magagna A, Abdel-Hag B. The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients. British Journal of Clinical Pharmacology 17: 1085–1115, 1984
Sandier DP, Burr R, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Annals of Internal Medicine 115: 165–172, 1991
Sawitzke AD, Jackson CG, Lundberg ML, Clegg DO, Williams HJ, et al. Serial liver biopsies from methotrexate-treated rheumatoid arthritis patients. Abstract no. 169. Arthritis and Rheumatism 34: S161, 1991
Scheiman JM, Behler EM, Bernardi RR, Elta GH. Salicylic acid causes less gastroduodenal mucosal damage than enteric-coated aspirin. Digestive Diseases and Sciences 34: 229–232, 1989
Schlegel SI, Paulus HE. Nonsteroidal and analgesic therapy in the elderly. Rheumatic Diseases Clinics of North America 12: 245–273, 1986
Scott DL, Roden S, Marshall T, Kendall MJ. Variations in response to nonsteroidal anti-inflammatory drugs. British Journal of Clinical Pharmacology 14: 691–694, 1982
Scully JS, Anderson CJ, Cannon GW. Long-term methotrexate therapy for rheumatoid arthritis. Seminars in Arthritis and Rheumatism 20: 317–331, 1991
Sedor JR, Williams SL, Chremos AN, Johnson CL, Dunn MJ. Effects of sulindac and indomethacin on renal prostaglandin synthesis. Clinical Pharmacology and Therapeutics 36: 85–91, 1984
Shallcross TM, Heatley RV. Effect of nonsteroidal anti-inflammatory drugs on dyspeptic symptoms. British Medical Journal 300: 368–369, 1990
Sherrer Y, Bloch D, Strober S, Fries J. Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis. Journal of Rheumatology 14: 46–51, 1987
Shiroky J. Low dose methotrexate with leucovorin rescue in the management of rheumatoid arthritis. Abstract no. 125. Arthritis and Rheumatism 34: S53, 1991
Skander MP, Ryan FP. Nonsteroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. British Medical Journal 297: 833–834, 1988
Smedley FH, Taube M, Leach R, Wastell C. Nonsteroidal anti-inflammatory drug ingestion: Retrospective study of 272 bleeding or perforated peptic ulcers. Postgraduate Medical Journal 65: 892–895, 1989
Smith MD, Bertouch JV, Smith AM, Weatherall M, Ahern MJ, et al. The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. 1. Clinical effects. Journal of Rheumatology 15: 229–232, 1988
Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Annals of Internal Medicine 114: 307–319, 1991
Somerville K, Faulkner G, Langman M. Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1: 462–464, 1986
Stern AI, Ward F, Hartley G. Protective effect of sucralfate against aspirin-induced damage to the human gastric mucosa. American Journal of Medicine 83 (Suppl. 38): 83–85, 1987
Strober S, Tanay A, Field E, Hoppe RT, Calin A, et al. Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis: a double-blind, randomized trial. Annals of Internal Medicine 102: 441–449, 1985
Swainson CP, Griffiths P. Acute and chronic effects of sulindac on renal function in chronic renal disease. Clinical Pharmacology and Therapeutics 37: 298–300, 1985
Tanay A, Field EH, Hoppe RT, Strober S. Long-term follow-up of rheumatoid arthritis patients treated with total lymphoid irradiation. Arthritis and Rheumatism 30: 1–10, 1987
Terkeltaub R, Esdaile J, Decary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. Journal of Rheumatology 10: 418–424, 1983
Thompson RN, Watt C, Edelman J, Esdaile J, Russell AS. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. Journal of Rheumatology 11: 760–763, 1984
Thorpe P. Rheumatoid arthritis treated with chlorambucil. A five-year follow-up. Medical Journal of Australia 2: 197–199, 1976
Tishler M, Caspi D, Fishel B, Yaron M. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis and Rheumatism 31: 906–908, 1988
Upton RA, Williams RL, Kelly J, Jones RM. Naproxen pharmacokinetics in the elderly. British Journal of Clinical Pharmacology 18: 207–214, 1984
Urowitz MB. Immunosuppressive therapy in rheumatoid arthritis. Journal of Rheumatology 1: 364–373, 1974
van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, van’t Hof MA, van Rujswijk MH. Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective follow-up study of early rheumatoid arthritis. Journal of Rheumatology 18: 1285–1289, 1991
Veys EM, Mielants H, Verbruggen G, Grosclaude JP, Meyer W, et al. Interferon-gamma in RA — a double blind study comparing human recombinant interferon gamma with placebo. Journal of Rheumatology 15: 570–574, 1988
Vollertsen RS, Conn DL, Ballard DJ, Ilstrup DM, Kazmar RE, et al. Rheumatoid vasculitis, survival and associated risk factors. Medicine 65: 365–375, 1986
Walan A, Bader JP, Classen M, Lamers CB, Piper DW, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. New England Journal of Medicine 320: 69–75, 1989
Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Clinical Gastroenterology 1: 489–492, 1986
Wasner C, Britton MC, Kraines G, Kaye RL, Bobrove AN, et al. Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis. Journal of American Medical Association 246: 168–172, 1981
Watkins J, Abbott EC, Hensby CN, Webster J, Dollery CT. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. British Medical Journal 281: 702–705, 1980
Weinblatt ME. Methotrexate. In Kelley et al. (Eds.) Textbook of rheumatology, 3rd ed., pp. 833–844, WB Saunders Co., Philadelphia, 1989
Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. New England Journal of Medicine 312: 818–822, 1985
Weir MR, Klassen DK, Hall PS, Schubert C, Voss TE, et al. Minimization of indomethacin-induced reduction in renal function by misoprostol. Journal of Clinical Pharmacology 31: 729–735, 1991
Weiss MM. Corticosteroids in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 19: 9–21, 1989
Whelton A, Stout RL, Spilman PS, Klassen DK. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. Annals of Internal Medicine 112: 568–576, 1990
Williams HJ, Reading JC, Ward JR, O’Brien WM. Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis. Arthritis and Rheumatism 23: 521–527, 1980
Wilske KR, Campbell PM. Network physician organization and guidelines for reviewers of rheumatic disease care. Bulletin on the Rheumatic Diseases 37: No. 2, 1987
Wolfe F, Cathey MA. The effect of age on methotrexate efficacy and toxicity. Journal of Rheumatology 18: 973–977, 1991
Wolfe F, Cathey MA, Hawley DJ. Improvement in gold treated rheumatoid arthritis patients: A second look at gold effectiveness in the community. Abstract no. 124. Arthritis and Rheumatism 34: S53, 1991
Wong DG, Spence JD, Lamki L, Freeman D, McDonald JWD. Effect of nonsteroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. Lancet 1: 997–1001, 1986
Wysenbeek AJ, Klein Z, Nakar S, Mane R. Assessment of cognitive function in elderly patients treated with naproxen: a prospective study. Clinical and Experimental Rheumatology 6: 399–400, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nesher, G., Moore, T.L. Rheumatoid Arthritis in the Aged. Drugs & Aging 3, 487–501 (1993). https://doi.org/10.2165/00002512-199303060-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199303060-00003